Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Rationale and methodology for a multicentre randomised trial of fibrinolysis for pulmonary embolism that includes quality of life outcomes.

Kline JA, Hernandez J, Hogg MM, Jones AE, Courtney DM, Kabrhel C, Nordenholz KE, Diercks DB, Rondina MT, Klinger JR.

Emerg Med Australas. 2013 Dec;25(6):515-26. doi: 10.1111/1742-6723.12159. Epub 2013 Nov 13.

PMID:
24224521
2.

Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial.

Kline JA, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT, Diercks DB, Klinger JR, Hernandez J.

J Thromb Haemost. 2014 Apr;12(4):459-68. doi: 10.1111/jth.12521.

3.

Fibrinolysis for patients with intermediate-risk pulmonary embolism.

Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galiè N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV; PEITHO Investigators.

N Engl J Med. 2014 Apr 10;370(15):1402-11. doi: 10.1056/NEJMoa1302097.

5.

Thrombolytic therapy for submassive pulmonary embolism.

Lankeit M, Konstantinides S.

Best Pract Res Clin Haematol. 2012 Sep;25(3):379-89. doi: 10.1016/j.beha.2012.06.005. Epub 2012 Aug 4. Review.

PMID:
22959553
6.

Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.

Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W; Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators.

N Engl J Med. 2002 Oct 10;347(15):1143-50.

7.

Should thrombolytic therapy be used in patients with pulmonary embolism?

Konstantinides S.

Am J Cardiovasc Drugs. 2004;4(2):69-74. Review.

PMID:
15049719
8.

Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism.

Stewart LK, Peitz GW, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT, Diercks DB, Klinger JR, Kline JA.

J Thromb Thrombolysis. 2015 Aug;40(2):161-6. doi: 10.1007/s11239-014-1155-5.

9.
11.

Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism.

Perlroth DJ, Sanders GD, Gould MK.

Arch Intern Med. 2007 Jan 8;167(1):74-80.

PMID:
17210881
12.

A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism.

Wells PS, Anderson DR, Rodger MA, Forgie MA, Florack P, Touchie D, Morrow B, Gray L, O'Rourke K, Wells G, Kovacs J, Kovacs MJ.

Arch Intern Med. 2005 Apr 11;165(7):733-8.

PMID:
15824291
13.

Fibrinolysis for Acute Care of Pulmonary Embolism in the Intermediate Risk Patient.

Meyer G, Planquette B, Sanchez O.

Curr Atheroscler Rep. 2015 Dec;17(12):68. doi: 10.1007/s11883-015-0546-1. Review.

PMID:
26486512
14.

Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism.

Becattini C, Agnelli G, Salvi A, Grifoni S, Pancaldi LG, Enea I, Balsemin F, Campanini M, Ghirarduzzi A, Casazza F; TIPES Study Group.

Thromb Res. 2010 Mar;125(3):e82-6. doi: 10.1016/j.thromres.2009.09.017. Epub 2009 Oct 14.

PMID:
19833379
15.

Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.

Camporese G, Bernardi E, Prandoni P, Noventa F, Verlato F, Simioni P, Ntita K, Salmistraro G, Frangos C, Rossi F, Cordova R, Franz F, Zucchetta P, Kontothanassis D, Andreozzi GM; KANT (Knee Arthroscopy Nadroparin Thromboprophylaxis) Study Group.

Ann Intern Med. 2008 Jul 15;149(2):73-82.

PMID:
18626046
16.
17.

Percutaneous rheolytic thrombectomy for large pulmonary embolism: a promising treatment option.

Chauhan MS, Kawamura A.

Catheter Cardiovasc Interv. 2007 Jul 1;70(1):121-8.

PMID:
17421019
18.

Thrombolysis in submassive pulmonary embolism, prudent or puerile?

Rehman A, Yousaf S, Chugh A.

BMJ Case Rep. 2013 Jan 24;2013. pii: bcr2012007549. doi: 10.1136/bcr-2012-007549.

19.

Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin.

Fasullo S, Scalzo S, Maringhini G, Ganci F, Cannizzaro S, Basile I, Cangemi D, Terrazzino G, Parrinello G, Sarullo FM, Baglini R, Paterna S, Di Pasquale P.

Am J Med Sci. 2011 Jan;341(1):33-9. doi: 10.1097/MAJ.0b013e3181f1fc3e.

PMID:
20890176
20.

Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group.

Hull RD, Raskob GE, Brant RF, Pineo GF, Elliott G, Stein PD, Gottschalk A, Valentine KA, Mah AF.

Arch Intern Med. 2000 Jan 24;160(2):229-36.

PMID:
10647762
Items per page

Supplemental Content

Write to the Help Desk